Warp Sciences
Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.
$215MSeries A
ParticipantLC
Lux Capital
Activity from announced rounds
Activity in this selectionBiotech
Lux Capital invests in companies emerging from the life sciences, physical sciences and computational sciences, including biotechnology, robotics, aerospace, defence and AI infrastructure.
Its investment approach includes small Seeds, Experiments and Optionality investments that let it engage with technology before a conventional venture case is established. The firm also makes thesis-driven investments and backs founders working on technically difficult problems.
Lux’s Riskgaming programme uses researched scenarios to examine how technological developments interact with geopolitics and national security. That perspective is especially relevant for founders whose commercial opportunity depends on scientific progress, industrial adoption or government demand.
Sources
- Rounds participated in
- 6
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $853M 6 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in this selectionWarhound
Warhound develops working dogs for military, law-enforcement and emergency-response teams.
$200MSeed
ParticipantEnveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantTransfyr
Physical AI platform capturing real-world lab science into machine-readable data
$25MSeed
Role not disclosedWaypoint Bio
Develops AI-designed CAR T therapies for solid tumors using spatial biology
$20MSeries A
Role not disclosedMendra
Develops and commercializes rare disease therapies using AI
$82MSeries A
Role not disclosed